Literature DB >> 4853356

Nitroheterocyclic drugs as selective radiosensitizers of hypoxic mammalian cells.

J D Chapman, A P Reuvers, J Borsa, J S Henderson, R D Migliore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4853356

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  6 in total

1.  Plasma concentrations and pharmacokinetics of misonidazole after intraperitoneal administration to the mouse.

Authors:  M F Malmary-Nebot; C Labat; M Terrissol; B Martin; J Oustrin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Jan-Mar       Impact factor: 2.441

2.  Structure-pharmacokinetic relationships for misonidazole analogues in mice.

Authors:  P Workman; J M Brown
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brain. A Southwest Oncology Group study.

Authors:  H J Eyre; J D Ohlsen; J Frank; A F LoBuglio; J D McCracken; T J Weatherall; C M Mansfield
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

4.  Studies with bleomycin and misonidazole on aerated and hypoxic cells.

Authors:  L Roizin-Towle; E J Hall
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

5.  Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.

Authors:  J M Brown; N Y Yu; P Workman
Journal:  Br J Cancer       Date:  1979-03       Impact factor: 7.640

6.  Ascorbate anion potentiates cytotoxicity of nitro-aromatic compounds under hypoxic and anoxic conditions.

Authors:  C J Koch; R L Howell; J E Biaglow
Journal:  Br J Cancer       Date:  1979-03       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.